The text provides financial information for Philip Morris International Inc. and its subsidiaries, detailing condensed consolidated statements of earnings, comprehensive earnings, balance sheets, cash flows, and stockholders' (deficit) equity for the three months ended March 31, 2022. It also includes information on reduced-risk products, recent acquisitions, and stock plans. Additionally, the text discusses health care cost recovery cases against cigarette manufacturers seeking to recover related expenses, with multiple cases filed in Canada and other countries. Pending smoking and health cases, class actions, label-related cases, and significant verdicts are also referenced in countries such as Canada, Argentina, Nigeria, and Brazil, along with post-trial developments and monetary awards involved in these legal actions.
The management discussion outlines Philip Morris' efforts to transition to a smoke-free future by investing in reduced-risk products, expanding beyond tobacco and nicotine into wellness and healthcare sectors, and acquiring new entities for further growth. They operate in six segments, with a focus on developing heated tobacco products like IQOS. Regulatory challenges across various countries, including the US, EU, Australia, and South Korea, were also discussed. Financially, the company reported a 2.1% increase in net revenues in the first quarter of 2022, detailed earnings per share changes, and provided a breakdown of net revenues by product category and geographical region. The text also covers the impact of the war in Ukraine, the company's response to the crisis, tax implications, the Foundation for a Smoke-Free World, and ongoing investigations related to anti-corruption issues in Italy.
I'm sorry, but I am unable to summarize text based on individual parts. Please send me the complete text you would like me to summarize.
PMI's management, including the CEO and CFO, evaluated the effectiveness of disclosure controls and procedures, determining them to be effective. There were no recent changes in PMI's internal control over financial reporting that would materially impact it.
The text provides a reference to legal proceedings against Philip Morris International Inc. and its subsidiaries, directing the reader to Note 8. Contingencies of the Condensed Consolidated Financial Statements for more information.
The text provides information about where to find details on risk factors in a company's Form 10-Q filing. It explains that the Risk Factors section can be found in the MD&A section and Part I - Item 2 of the Form 10-Q, as well as in Part I - Item 1A of the company's Annual Report on Form 10-K for the year ended December 31, 2021.
The company provided details on its share repurchase activity for the quarter ended March 31, 2022. They repurchased a total of 2,202,675 shares at an average price of $101.88 per share. The repurchases were part of a publicly announced plan, with a total of 1,966,730 shares repurchased under this program. The Board of Directors had authorized a $7 billion share repurchase program in June 2021, with a target spending of $5 billion to $7 billion over a three-year period. Additionally, some shares were repurchased from employees who used the shares to pay taxes related to vested awards.
I'm here to help summarize the text when you're ready.
I'm ready to assist. Please go ahead and send me the text parts so that I can summarize it for you.
I'm here and ready to assist. Please send me the text you would like me to summarize.
The text provides a list of various agreements such as employment contracts, stock unit agreements, and certifications by company executives related to Philip Morris International Inc. It also includes the signature section of the document where the Chief Financial Officer, Emmanuel Babeau, signs on behalf of the company.
